A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
Conditions
Unresectable Gastrointestinal Stromal Tumor (GIST) · Locally Advanced Gastrointestinal Stromal Tumor (GIST) · Metastatic Gastrointestinal Stromal Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre Léon Bérard, Lyon, Rhône, France
Institut Bergonié, Bordeaux, France
Centre Oscar Lambret, Lille, France
Hôpital de La Timone, Marseille, France
Centre Antoine Lacassagne, Nice, France
CHU Poitiers, Poitiers, France
Hôpital Robert Debré, Reims, France
Centre Eugène Marquis, Rennes, France
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Centre Paul Strauss, Strasbourg, France
ICANS CHRU de Strasbourg, Strasbourg, France
Chru Tours, Tours, France
Institut Gustave Roussy, Villejuif, France
Study leads
Mehdi BRAHMI, MD
Principal Investigator
Centre Leon Berard